HHS recently released “100 Days of Action on the President’s American Patients First Blueprint.”

Some of the information looks great, such as 60% fewer brand-drug price increases than the same period in 2017 and a record breaking 126 generics approved in July.  Additionally, 4 drug companies canceled planned price increases and 13 committed to price freezes for the rest of 2018.

Pharmaceutical pricing and fees have become the health care industry’s best kept secret. The cost of prescription drugs are increasing at an unsustainable rate, and to make matters worse the revenue sources aren’t transparent to the patient or employer. 

• Prescription drug spending in 2016 accounted for 10% of the nation's total health care costs.
• Prices for common medications are as much as 117% higher in the United States than in other nations.